Dandelion Health Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$14M
- Investors
-
9
Dandelion Health General Information
Description
Developer of a clinical and artificial intelligence and real-world data platform intended to support research, patient phenotyping, and drug development. The company integrates de-identified multimodal clinical data from millions of patient records into regulatory-grade, research-ready datasets, enabling biopharmaceutical companies, researchers, and healthcare organizations to study disease progression, treatment response, and trial population characteristics.
Contact Information
Website
www.dandelionhealth.aiCorporate Office
- 1850 Muttontown Road
- Syosset
- New York, NY 11791-9652
- United States
Corporate Office
- 1850 Muttontown Road
- Syosset
- New York, NY 11791-9652
- United States
Dandelion Health Timeline
Dandelion Health Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series A) | 05-May-2026 | $14M | Completed | Generating Revenue | ||
| 1. Seed Round | 29-Feb-2024 | Completed | Generating Revenue |
Dandelion Health Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-2 | ||||||||
| Seed-1 | ||||||||
| Seed | 2,270,960 | $0.000010 | $3.34 | $3.34 | 1x | $3.34 | 12.23% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Dandelion Health Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Dandelion Health Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Dandelion Health Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Colle Capital Partners | Venture Capital | Minority | ||
| Coller Capital | Secondary Buyer | Minority | ||
| Healthier Capital | Venture Capital | Minority | ||
| Convergent Ventures (San Francisco) | Venture Capital | Minority | ||
| Floating Point (Boston) | Venture Capital | Minority |
Dandelion Health FAQs
-
When was Dandelion Health founded?
Dandelion Health was founded in 2020.
-
Where is Dandelion Health headquartered?
Dandelion Health is headquartered in New York, NY.
-
What is the size of Dandelion Health?
Dandelion Health has 20 total employees.
-
What industry is Dandelion Health in?
Dandelion Health’s primary industry is Other Healthcare Technology Systems.
-
Is Dandelion Health a private or public company?
Dandelion Health is a Private company.
-
What is Dandelion Health’s current revenue?
The current revenue for Dandelion Health is .
-
How much funding has Dandelion Health raised over time?
Dandelion Health has raised $29.9M.
-
Who are Dandelion Health’s investors?
Colle Capital Partners, Coller Capital, Healthier Capital, Convergent Ventures (San Francisco), and Floating Point (Boston) are 5 of 9 investors who have invested in Dandelion Health.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
